| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Okt―28 |
Influenza in Australia before, during and after the COVID-19 pandemic |
Ian G. Barr |
| 2 |
[GO] |
2024―Okt―28 |
COVID-19 vaccine effectiveness monitoring in Australia |
Bette Liu |
| 3 |
[GO] |
2024―Okt―28 |
Recent pandemics and informed predictions |
Stanley Perlman |
| 4 |
[GO] |
2024―Aug―29 |
Corrigendum to: An update on Long COVID |
Gary Grohmann, Robert Booy |
| 5 |
[GO] |
2024―Aug―19 |
High pathogenicity avian influenza in Australia and beyond: could avian influenza cause the next human pandemic? |
Megan Airey, Kirsty R. Short |
| 6 |
[GO] |
2024―Mrz―22 |
Cellular signalling by SARS-CoV-2 spike protein |
Nicholas P. Gracie, Lachlan Y. S. Lai, Timothy P. Newsome |
| 7 |
[GO] |
2024―Mrz―21 |
Contextualising COVID-19 in 2024 |
Gregory Walker, William Rawlinson |
| 8 |
[GO] |
2024―Mrz―19 |
Pandemic lessons learned and future public health strategies |
Brett Sutton |
| 9 |
[GO] |
2024―Mrz―15 |
Australia’s COVID-19 vaccine journey: progress and future perspectives |
James A. Triccas, Megan C. Steain |
| 10 |
[GO] |
2024―Mrz―15 |
An update on Long COVID |
Gary Grohmann, Robert Booy |
| 11 |
[GO] |
2024―Mrz―13 |
Wastewater-based SARS-CoV-2 surveillance and sequencing |
Alice Michie |
| 12 |
[GO] |
2024―Mrz―08 |
The evolving epidemiology of SARS-CoV-2 |
Catherine M. Bennett, Hassan Vally |
| 13 |
[GO] |
2024―Mrz―05 |
A brief survey of interventional agents intended to treat Long COVID |
Ross T. Barnard, Evan B. Siegel |
| 14 |
[GO] |
2023―Nov―16 |
The 2020 İzmir earthquake and its effect on COVID-19 cases |
Seyfi Durmaz, Gönül Aslan, Raika Durusoy, Candan Çiçek |
| 15 |
[GO] |
2023―Jul―14 |
Redevelopment of undergraduate food microbiology capstone projects for unprecedented emergency remote teaching during the COVID-19 pandemic: then and now |
Yianna Zhang, Chaminda Senaka Ranadheera |
| 16 |
[GO] |
2023―Mai―18 |
Long COVID |
Kirsty R. Short |
| 17 |
[GO] |
2022―Apr―28 |
Reflections from Melbourne, the world’s most locked-down city, through the COVID-19 pandemic and beyond |
Ian Macreadie |
| 18 |
[GO] |
2022―Apr―14 |
Vaccine technologies used to develop COVID-19 vaccines |
Paul Selleck, Ian Macreadie |
| 19 |
[GO] |
2021―Nov―19 |
COVID-19 in Fiji |
Patrick C Reading, Richard A Strugnell |
| 20 |
[GO] |
2021―Nov―11 |
Avian influenza H5N1: still a pandemic threat? |
Paul F Horwood |
| 21 |
[GO] |
2021―Okt―29 |
Development of container laboratories in response to COVID-19 |
Russell Cole |
| 22 |
[GO] |
2021―Sep―07 |
Reflections on the COVID-19 pandemic from a university academic |
Ian Macreadie |
| 23 |
[GO] |
2021―Mai―27 |
Lipids, statins and susceptibility to SARS-CoV-2 and influenza A viruses |
Melissa Carabott, Ryan Case, Sudip Dhakal, Ian Macreadie |
| 24 |
[GO] |
2021―Apr―27 |
Corrigendum to: Therapeutics for COVID-19: established and in development |
Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley |
| 25 |
[GO] |
2021―Apr―27 |
Contextualising SARS Coronavirus 2 and COVID-19 |
William Rawlinson |
| 26 |
[GO] |
2021―Apr―12 |
Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19) |
Erik De Clercq |
| 27 |
[GO] |
2021―Apr―12 |
Vaccination for COVID-19 control and considerations for Australia |
Raina MacIntyre |
| 28 |
[GO] |
2021―Apr―12 |
Role of testing for the COVID-19 response in Aboriginal, Torres Strait Islander and regional populations |
David Speers |
| 29 |
[GO] |
2021―Apr―12 |
The threat of zoonotic coronaviruses |
Matthew J Gartner, Kanta Subbarao |
| 30 |
[GO] |
2021―Apr―12 |
Wastewater monitoring for SARS-CoV-2 |
Erica Donner, Arash Zamyadi, Aaron Jex, Michael Short, Barbara Drigo, David McCarthy, Nicholas Crosbie, Warish Ahmed, Jochen Mueller, Kevin Thomas, Paul Monis, Alex Keegan, Maneesha Ginige, Philip Hugenholtz, Gene Tyson, Kelly Hill, Linda Blackall |
| 31 |
[GO] |
2021―Apr―12 |
Long-term and short-term immunity to SARS-CoV-2: why it matters |
John Zaunders, Chansavath Phetsouphanh |
| 32 |
[GO] |
2021―Apr―12 |
Responding to the pandemic at a national and state public health level |
Sonya Bennett |
| 33 |
[GO] |
2021―Apr―09 |
Genome sequencing and its use in public health responses to COVID-19 |
John-Sebastian Eden |
| 34 |
[GO] |
2021―Apr―09 |
COVID-19 in animals: contact with humans and potential transmissions |
Paul Selleck |
| 35 |
[GO] |
2021―Apr―09 |
Genes of SARS-CoV-2 and emerging variants |
Sudip Dhakal, Ian Macreadie |
| 36 |
[GO] |
2020―Nov―10 |
Therapeutics for COVID-19: established and in development |
Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley |
| 37 |
[GO] |
2020―Okt―27 |
What history teaches us about vaccines and pandemics |
David Isaacs |
| 38 |
[GO] |
2020―Okt―22 |
Understanding the SARS-CoV-2 pandemic as evolution in action |
Will Cairns |
| 39 |
[GO] |
2020―Okt―07 |
The 1918 Spanish influenza pandemic: plus ça change, plus ça change, plus c’est la même chose |
Paul Selleck, Ross Barnard |
| 40 |
[GO] |
2020―Aug―18 |
The SARS-CoV-2 ‘perfect storm |
Annaleise R Howard-Jones, Jen Kok |
| 41 |
[GO] |
2020―Mai―27 |
Disease X ver1.0: COVID-19 |
Paul R Young |
| 42 |
[GO] |
2020―Apr―03 |
What serosurveillance studies tell us about the 2009 influenza pandemic |
Gary K Dowse, Ian Barr |
| 43 |
[GO] |
2020―Apr―03 |
How did the 2009 pandemic compare with previous pandemics? |
John D Matthews |
| 44 |
[GO] |
2020―Apr―03 |
Diagnosis of influenza following the first wave of pandemic (H1N1) 2009 influenza |
Jen Kok, Dominic E Dwyer |
| 45 |
[GO] |
2020―Apr―03 |
Pandemic H1N1 2009 influenza in pigs in Australia |
Frank YK Wong, Yi-Mo Deng |
| 46 |
[GO] |
2020―Apr―03 |
Laboratory diagnosis of influenza and the impact of the pandemic (H1N1) 2009 virus |
Jen Kok, David W Smith, Dominic E Dwyer |
| 47 |
[GO] |
2020―Apr―03 |
Antiviral drug resistance in seasonal and pandemic influenza |
Aeron C Hurt |
| 48 |
[GO] |
2020―Apr―03 |
The origins of pandemic influenza ? a perspective |
Graeme Laver |
| 49 |
[GO] |
2020―Apr―03 |
Clinical impact of influenza - lessons learnt from the pandemic influenza A (H1N1) 2009 |
Alex Dierig, Gulam Khandaker, Robert Booy |
| 50 |
[GO] |
2020―Apr―03 |
H1N1 2009 pandemic influenza in Indigenous Australians |
Peter Markey, Jiunn-Yih Su, Andre Wattiaux, James Trauer, Vicki Krause |
| 51 |
[GO] |
2020―Apr―03 |
Development and testing of the Australian pandemic influenza vaccine - a timely response |
Steven Rockman, Peter Schoofs, Michael Greenberg |
| 52 |
[GO] |
2020―Apr―03 |
Regulatory issues in pandemic influenza vaccine development |
Gary Grohmann |
| 53 |
[GO] |
2020―Apr―03 |
Pandemic planning: the Australian response |
Moira McKinnon |
| 54 |
[GO] |
2020―Apr―03 |
Development of an Australian pandemic vaccine |
David Ryan |
| 55 |
[GO] |
2020―Apr―03 |
T-cell immunity against the A(H1N1) 2009 pandemic virus |
Sophie A Valkenburg, Karen Laurie, Anne Kelso, Stephen J Turner, Peter C Doherty, Katherine Kedzierska |
| 56 |
[GO] |
2020―Apr―03 |
‘Dengue: Australia’s other pandemic’ |
Scott A Rithchie |
| 57 |
[GO] |
2020―Apr―03 |
Preparing for the influenza pandemic: the government response |
Moira McKinnon |
| 58 |
[GO] |
2020―Mrz―17 |
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't |
John S Mackenzie, David W Smith |
